UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of women with multiple sclerosis through pregnancy and after childbirth

Therapeutic Advances in Neurological Disorders, 2016-05, Vol.9 (3), p.198-210

Coyle, Patricia K.

2016

Volltextzugriff (PDF)

Establishing the proteome of normal human cerebrospinal fluid

PloS one, 2010-06, Vol.5 (6), p.e10980-e10980

2010

Volltextzugriff (PDF)

Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial

Lancet neurology, 2014-03, Vol.13 (3), p.257-267

2014

Volltextzugriff (PDF)

Central Nervous System Vasculitis due to Infection

Neurologic clinics, 2019-05, Vol.37 (2), p.441-463

2019

Volltextzugriff (PDF)

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

Lancet neurology, 2008-10, Vol.7 (10), p.903-914

2008

Volltextzugriff (PDF)

Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome

PloS one, 2011-02, Vol.6 (2), p.e17287-e17287

2011

Volltextzugriff (PDF)

What Can We Learn from Sex Differences in MS?

Journal of personalized medicine, 2021-10, Vol.11 (10), p.1006

Coyle, Patricia K

2021

Volltextzugriff (PDF)

Integrated Lymphopenia Analysis in Younger and Older Patients With Multiple Sclerosis Treated With Cladribine Tablets

Frontiers in immunology, 2021-12, Vol.12, p.763433-763433

2021

Volltextzugriff (PDF)

Sphingosine 1‐phosphate receptor modulators in multiple sclerosis treatment: A practical review

Annals of clinical and translational neurology, 2024-04, Vol.11 (4), p.842-855

2024

Volltextzugriff (PDF)

Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives

Multiple Sclerosis International, 2017-01, Vol.2017 (2017), p.53-62

2017

Volltextzugriff (PDF)

Ofatumumab versus Teriflunomide in Multiple Sclerosis

The New England journal of medicine, 2020-08, Vol.383 (6), p.546-557

2020

Volltextzugriff (PDF)

High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis

CNS drugs, 2022-12, Vol.36 (12), p.1285-1299

2022

Volltextzugriff (PDF)

Gray matter is targeted in first-attack multiple sclerosis

PloS one, 2013-09, Vol.8 (9), p.e66117-e66117

2013

Volltextzugriff (PDF)

Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives

Neurology and therapy, 2024-04, Vol.13 (2), p.283-322

2024

Volltextzugriff (PDF)

Commentary: The Multiple Sclerosis Controversy: Is It Escalation or Induction High Efficacy?

Neurotherapeutics, 2020-07, Vol.17 (3), p.971-972

Coyle, Patricia K.

2020

Volltextzugriff (PDF)

Clinical Neuroimmunology: Multiple Sclerosis and Related Disorders

Second edition., 2019

Volltextzugriff (PDF)

DMTs should be trialed in individuals with PPMS and SPMS with or without recent disease activity – Yes

Multiple sclerosis, 2022-02, Vol.28 (2), p.183-185

2022

Volltextzugriff (PDF)

Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis

BMC neurology, 2020-10, Vol.20 (1), p.364-364, Article 364

2020

Volltextzugriff (PDF)

The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review

Drugs (New York, N.Y.), 2020-12, Vol.80 (18), p.1901-1928

2020

Volltextzugriff (PDF)

Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era

Advances in therapy, 2021-07, Vol.38 (7), p.3550-3588

2021

Volltextzugriff (PDF)

Switching Therapies in Multiple Sclerosis

CNS drugs, 2013-04, Vol.27 (4), p.239-247

Coyle, Patricia K.

2013

Volltextzugriff (PDF)

Interleaved Carbon Minibeams: An Experimental Radiosurgery Method With Clinical Potential

International journal of radiation oncology, biology, physics, 2012-10, Vol.84 (2), p.514-519

2012

Volltextzugriff (PDF)

Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?

Multiple sclerosis, 2017-04, Vol.23 (4), p.604-613

2017

Volltextzugriff (PDF)

Disease-modifying treatment, long-term outcomes and transition to progressive multiple sclerosis: data based on the New York State MS Consortium

Journal of neurology, 2024-02, Vol.271 (2), p.711-722

2024

Volltextzugriff (PDF)

Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience

Multiple sclerosis, 2020-06, Vol.26 (7), p.829-836

2020

Volltextzugriff (PDF)

1 – 25 von 186

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(136)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(186)

Erscheinungsjahr

n.n

Thema

Science & Technology
(126)
Life Sciences & Biomedicine
(122)
Humans
(90)
Neurosciences & Neurology
(83)
Clinical Neurology
(81)
Multiple Sclerosis
(59)
Female
(53)
Adult
(49)
Male
(48)
Middle Aged
(39)
Neurosciences
(31)
Neurology
(26)
Immunology
(25)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Adolescent
(18)
Multiple Sclerosis - Drug Therapy
(18)
Magnetic Resonance Imaging
(17)
Medicine
(15)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of women with multiple sclerosis through pregnancy and after childbirth

Establishing the proteome of normal human cerebrospinal fluid

Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial

Central Nervous System Vasculitis due to Infection

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome

What Can We Learn from Sex Differences in MS?

Integrated Lymphopenia Analysis in Younger and Older Patients With Multiple Sclerosis Treated With Cladribine Tablets

Sphingosine 1‐phosphate receptor modulators in multiple sclerosis treatment: A practical review

Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives

Ofatumumab versus Teriflunomide in Multiple Sclerosis

High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis

Gray matter is targeted in first-attack multiple sclerosis

Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives

Commentary: The Multiple Sclerosis Controversy: Is It Escalation or Induction High Efficacy?

Clinical Neuroimmunology: Multiple Sclerosis and Related Disorders

DMTs should be trialed in individuals with PPMS and SPMS with or without recent disease activity – Yes

Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis

The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review

Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era

Switching Therapies in Multiple Sclerosis

Interleaved Carbon Minibeams: An Experimental Radiosurgery Method With Clinical Potential

Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?

Disease-modifying treatment, long-term outcomes and transition to progressive multiple sclerosis: data based on the New York State MS Consortium

Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience

Suchergebnisse filtern